A: Hospitalized patients with pneumonia who develop a complicated parapneumonic effusion or empyema need to undergo chest tube placement.
■ WHAT IS PARAPNEUMONIC EFFUSION?
Parapneumonic effusion is a pleural effusion that forms concurrently with bacterial or viral pneumonia. Up to 40% of patients hospitalized with pneumonia develop a parapneumonic effusion. 1 The effusion progresses through a continuum of 3 stages: uncomplicated, complicated, and empyema.
Uncomplicated parapneumonic effusion is an exudative effusion without bacteria or pus that is caused by movement of fl uid and neutrophils into the pleural space. Pneumonia itself causes an increase in interstitial fl uid and capillary leakage. The effusion becomes complicated as a result of bacteria invading the pleural space, causing a further increase in neutrophils in the pleural fl uid. Empyema is defi ned as the presence of frank pus in the pleural space.
■ CLINICAL SIGNIFICANCE
According to the US Centers for Disease Control and Prevention, pneumonia accounts for 674,000 emergency department visits each year; of the patients hospitalized, up to 40% develop a parapneumonic effusion. 2 The only study done on rates of death associated with parapneumonic effusion showed that, compared with patients with no effusion, the risk of death was 3.7 times higher with a unilateral effusion and 6.5 times higher with bilateral effusions. 3 
■ INITIAL EVALUATION
The initial evaluation of suspected parapneumonic effusion should include chest radiography with lateral or decubitus views, followed by thoracentesis if indicated. If thoracentesis is performed, the fl uid should be tested as follows: 
■ CLASSIFICATION OF EFFUSIONS
When pleural fl uid is obtained, the total protein and LDH levels are used to categorize the effusion as either transudative or exudative based on the Light criteria. 4 An effusion is confi rmed as exudative when 1 of the following 3 criteria is met: • The ratio of pleural fl uid protein to serum protein is greater than 0.5 • The ratio of pleural fl uid LDH to serum LDH is greater than 0.6 • The pleural fl uid LDH is greater than twothirds the upper limit of normal for the serum LDH.
Once an effusion is characterized as exudative, the American College of Chest Physicians consensus guidelines are used for further classifi cation and prognostication. 5 The guidelines estimate the risk of poor outcome by dividing the effusions based on their characteristics: the anatomy of the effusion, the bacteriology of the fl uid, and the chemistry of the pleural fl uid ( Category 1 effusions are defi ned as freefl owing fl uid with a thickness of less than 10 mm on any imaging modality. Thoracentesis for pleural fl uid analysis is not required. The prognosis is very good. Category 2 effusions are defi ned as freefl owing fl uid with a thickness greater than 10 mm and less than 50% of the hemithorax. Thoracentesis is typically done because of the size of the effusion, but Gram stain and culture of the pleural fl uid are usually negative, and the pH is at least 7.2. The prognosis is good.
Category 3 effusions are considered complicated because the anatomy of the pleural space becomes altered or because bacteria have invaded the pleural space. The effusion is larger than 50% of the hemithorax or is loculated, or the parietal pleura is thickened. Since the bacteria have invaded the pleural space, Gram stain or culture of pleural fl uid may be positive, the pleural fl uid pH may be less than 7.2, or the glucose level of the fl uid may be less than 60 mg/dL. The prognosis for category 3 is poor.
Category 4 effusions are defi ned as empyema. The only characteristic that separates this from category 3 is frank pus in the pleural space. The prognosis is very poor.
■ TO PLACE A CHEST TUBE OR NOT
For category 1 or 2 effusions, treatment with antibiotics alone is typically enough. Category 3 effusions usually do not respond to antibiotics alone and may require complete drainage of the fl uid with or without a chest tube depending on whether loculations are present, as loculations are diffi cult to drain with a chest tube. Category 4 effusions require both antibiotics and chest tube placement.
■ WHAT TYPE OF CHEST TUBE?
Studies have shown that small-bore chest tubes (< 20 F) are as effi cacious as larger tubes (≥ 20 F) for the treatment of complicated parapneumonic effusion and empyema. 6, 7 Studies have also shown that the size of the tube makes no difference in the time needed to drain the effusion, the length of hospital stay, or the complication rate. 8, 9 Based on these studies, a small-bore chest tube should be placed fi rst when clinically appropriate. When a chest 
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tube is placed for empyema, computed tomography should be performed within 24 hours to confi rm proper tube placement.
■ ADVANCED THERAPIES FOR EMPYEMA
Empyema treatment fails when antibiotic coverage is inadequate or when a loculation is not drained appropriately. Options if treatment fails include instillation of fi brinolytics into the pleural space, video-assisted thorascopic surgery, and decortication. The role of fi brinolytics has not been wellestablished, but fi brinolytics should be considered in loculated effusions or empyema, or if drainage of the effusion slows. 10 Videoassisted thora scopic surgery is reserved for effusions that are incompletely drained with a chest tube with or without fi brinolytics; studies have shown shorter hospital length of stay and higher treatment effi cacy when this is performed earlier for loculated effusions. 11 Decortication is reserved for symptomatic patients who have a thickened pleura more than 6 months after the initial infection. 12 Timing for each of these procedures is not clearly defi ned and so must be individualized. 
